Emergent BioSolutions (EBS) Tops Q2 EPS by 26c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.24 -0.48%
EPS Growth %: -31.3%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: -31.3%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.16, $0.26 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $140.9 million versus the consensus estimate of $174 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
- Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight
- Nvidia Says "Our Roadmap Is Intact" In Response To Delay Report - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
